Actively Recruiting
Effect of Ultrasound-guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Laparoscopic Gastrostomy: A Prospective Randomized Controlled Trial
Led by Seoul National University Hospital · Updated on 2025-08-13
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of an ultrasound-guided external oblique intercostal fascial plane (EOI) block to reduce pain during and after laparoscopic gastrostomy surgery in children ages 3 to 18 years. This randomized controlled trial compares the effects of the EOI block using ropivacaine against a sham block using normal saline to understand its impact on heart rate changes and pain management during surgery. Participants will be randomly assigned to receive either a bilateral EOI block with 0.25% ropivacaine or a sham block with normal saline, both performed under ultrasound guidance. The study measures include the percent change in heart rate at the time of surgical incision as the primary outcome, along with secondary outcomes such as fentanyl use during surgery, various pain scores, analgesia nociception index values, and any analgesia-related side effects. During the study, children's pain levels will be monitored at multiple time points after surgery using standardized pain scales. Researchers will also track the use of pain medications up to 24 hours post-operation and monitor for any adverse effects related to analgesia. The trial is conducted under general anesthesia, and heart rate and blood pressure changes will be recorded around the time of surgery to evaluate the intervention's effectiveness.
CONDITIONS
Brief Title
EOI Block for Laparoscopic Gastrostomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for laparoscopic gastrostomy at Seoul National University Children's Hospital
- Age 3 years or older and less than 18 years
You will not qualify if you...
- Unstable vital signs
- Contraindications to ropivacaine or opioids
- Severe hepatic or renal dysfunction
- Other investigator-determined ineligibility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants undergo laparoscopic gastrostomy surgery with either the EOI block or a sham block under ultrasound guidance, followed by immediate post-operative monitoring.
1 surgical visit and monitoring in PACU for up to 30 minutes
Duration - 24 hours after surgery
Participants are monitored for pain and analgesic use up to 24 hours after surgery.
Assessments at 15 and 30 minutes in PACU, and at 1, 3, 6, and 24 hours post-surgery
Trial Site Locations
Total: 1 location
1
Seoul National University Children's Hospital
Seoul, South Korea, 110-744
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here